Published in Transplant Proc on December 01, 1987
Liver transplantation (1). N Engl J Med (1989) 4.53
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74
B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45
Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology (1992) 1.18
Prospects of clinical xenotransplantation. Transplant Proc (1994) 0.98
Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells. Stem Cells Transl Med (2015) 0.85
Human liver xenotransplantation. Xeno (1993) 0.81
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc (1995) 0.80
The Future of Xenotransplantation. Ann Surg (1992) 0.80
Strategies to overcome the ABO barrier in kidney transplantation. Nat Rev Nephrol (2015) 0.78
Transplantation: the realization of a dream. Semin Nucl Med (1988) 0.75
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
The histological distribution of blood group substances A and B in man. J Exp Med (1960) 3.79
"Hyperacute" renal-homograft rejection in man. N Engl J Med (1968) 3.37
Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25
RENAL HOMOGRAFTS IN PATIENTS WITH MAJOR DONOR-RECIPIENT BLOOD GROUP INCOMPATIBILITIES. Surgery (1964) 2.16
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery (1978) 1.50
The principle of mixed agglutination applied to tissue culture systems; a method for study of cell-bound blood-group antigens. Vox Sang (1959) 1.29
THE INCIDENCE, CAUSE, AND SIGNIFICANCE OF IMMEDIATE AND DELAYED OLIGURIA OR ANURIA AFTER HUMAN RENAL TRANSPLANTATION. Surg Gynecol Obstet (1964) 1.18
Selective plasmapheresis in dogs for delay of heterograft response. Trans Am Soc Artif Intern Organs (1970) 1.14
Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc (1971) 1.08
Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens. J Clin Invest (1968) 0.98
Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet (1985) 0.95
Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate. Surgery (1971) 0.93
Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation (1985) 0.89
Modification of xenograft response by selective plasmapheresis. Transplant Proc (1971) 0.88
Liver transplantation. N Engl J Med (1984) 0.87
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Kidney transplantation under FK 506. JAMA (1990) 7.45
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73
IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. Surg Res Commun (1987) 4.68
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth (2001) 3.47
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Aftermath of surgery for anorectal cancer. Br Med J (1971) 3.27
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87
Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
Liver transplantation across ABO blood groups. Surgery (1986) 2.39
Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37
The antibody crossmatch in liver transplantation. Surgery (1986) 2.33
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
The Second National Prevalence Survey of infection in hospitals--overview of the results. J Hosp Infect (1996) 2.32
Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant (2011) 2.28
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26
Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25
Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25
Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21
Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20
Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg (2005) 2.19
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17
Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15
Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10
A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Commun Dis Rep CDR Rev (1994) 2.04
The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients. J Okla State Med Assoc (1995) 2.02
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90
Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89
Predicting hospital mortality for patients in the intensive care unit: a comparison of artificial neural networks with logistic regression models. Crit Care Med (2001) 1.86
Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85
The nature and mode of action of the cellulolytic component C1 of Trichoderma koningii on native cellulose. Biochem J (1973) 1.85
Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet (1989) 1.82
Analysis of the growth of recombination-deficient strains of Escherichia coli K-12. J Bacteriol (1974) 1.82
Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc (1990) 1.80
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77
Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74
Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg (2001) 1.72
Effects of leukotriene D on the airways in asthma. N Engl J Med (1983) 1.69
'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology (2002) 1.68
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation (1989) 1.67
Cyclosporine A augments the regenerative response after partial hepatectomy in the rat. Transplant Proc (1988) 1.64
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection (2009) 1.64
Liver transplantation: an unfinished product. Transplant Proc (1989) 1.61
Liver transplantation for polycystic liver disease. Arch Surg (1990) 1.61
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha. Am J Surg Pathol (1997) 1.60
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59
Microbiological hazards related to xenotransplantation of porcine organs into man. Infect Control Hosp Epidemiol (1998) 1.58
Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation (1989) 1.58
The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg (1988) 1.56
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc (1987) 1.56